The patients exhibiting tau pathology alone were left out of the analyses between the different AD-related pathologies due to the small sample size (n = 3), but further investigation into the patients with tau pathology would be of interest due to the significant differences in the individual CSF profiles when compared to the rest of the study population. This evidence concerns the gene MAPT and Alzheimer disease.